このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Diaphragmatic Facilitation and Upper Extremity Performance in Volleyball Players

2026年8月25日 更新者：Kubra Kardes、Istinye University

Immediate Effects of Diaphragmatic Facilitation on Upper Extremity Performance in Volleyball Players

The diaphragm contributes to both respiration and trunk stabilization. Effective diaphragmatic function may support postural control, force transfer, and upper extremity performance during dynamic activities. However, evidence regarding the immediate effects of manual diaphragmatic facilitation on upper extremity performance in athletes remains limited.

This study aims to investigate the immediate effects of manual diaphragmatic facilitation on upper extremity performance and respiratory function in actively participating volleyball players. Participants will receive an approximately 15-minute session of manual diaphragmatic facilitation. Pulmonary function, respiratory muscle strength, and upper extremity strength, stability, and endurance will be assessed immediately before and after the intervention. Assessments will include spirometry, maximal inspiratory and expiratory pressures, the Medicine Ball Throw Test, the Closed Kinetic Chain Upper Extremity Stability Test, and the Scapular Endurance Test.

調査の概要

状態

募集

条件

介入・治療

研究の種類

介入

入学 (推定)

50

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人

健康ボランティアの受け入れ

はい

説明

Inclusion Criteria:

  • Aged between 18 and 30 years.
  • Regularly participating in volleyball for at least one year.
  • Training at least twice per week or actively participating in volleyball at the league or tournament level.
  • No history of a serious upper extremity or trunk injury within the previous six months, i-including injuries affecting the shoulder, scapular region, or spine.
  • No diagnosed chronic respiratory disease, including asthma, chronic obstructive pulmonary disease, or allergic bronchitis.
  • Willing and able to provide written informed consent.

Exclusion Criteria:

  • History of surgery involving the upper extremity, spine, or trunk within the previous six months, including shoulder arthroscopy or spinal disc surgery.
  • Presence of an active musculoskeletal injury, including tendinopathy, bursitis, or ligament injury.
  • Presence of a diagnosed respiratory disease, including asthma, chronic obstructive pulmonary disease, or bronchiectasis.
  • Presence of a diagnosed postural or spinal deformity that may affect study assessments, including scoliosis, clinically significant kyphosis, or clinically significant lordosis.
  • History of a neurological or cardiovascular disease.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか？

デザインの詳細

  • 主な目的：処理
  • 割り当て：ランダム化
  • 介入モデル：並列代入
  • マスキング：ダブル

武器と介入

参加者グループ / アーム
介入・治療
実験的：Intervention Group
Diaphragmatic Facilitation Group
他の：Diaphragmatic Facilitation
Following a standardized dynamic warm-up, participants in the intervention group will receive a single session of manual resisted diaphragmatic facilitation.
実験的：Control Group
Sham Control Group
他の：Sham Facilitation
Participants in the control group will complete the same dynamic warm-up protocol, followed by a sham intervention consisting of superficial, non-facilitatory palpation and general breathing instructions.

この研究は何を測定していますか？

主要な結果の測定

結果測定
メジャーの説明
時間枠
Forced Vital Capacity
時間枠：4 weeks
Forced vital capacity is the maximum volume of air that a participant can forcibly exhale after taking the deepest possible breath. It will be measured by spirometry and recorded in liters. Higher values generally indicate greater ventilatory capacity, whereas lower values may indicate reduced pulmonary capacity or expiratory limitation.
4 weeks
Forced Expiratory Volume in One Second
時間枠：4 weeks
Forced expiratory volume in one second is the volume of air that a participant can forcibly exhale during the first second of a forced expiratory maneuver. It will be measured by spirometry and recorded in liters. Higher values generally indicate better expiratory airflow, whereas lower values may indicate reduced expiratory airflow.
4 weeks
Ratio of Forced Expiratory Volume in One Second to Forced Vital Capacity
時間枠：4 weeks
The ratio of forced expiratory volume in one second to forced vital capacity represents the proportion of the forced vital capacity exhaled during the first second of a forced expiratory maneuver. It will be calculated from spirometric measurements and reported as a percentage. Higher values generally indicate a greater proportion of air expelled during the first second, whereas lower values may indicate expiratory airflow limitation. The results will be interpreted with consideration of age- and sex-appropriate reference values.
4 weeks
Maximal Inspiratory Pressure
時間枠：4 weeks
Maximal inspiratory pressure will be used to assess inspiratory muscle strength, primarily reflecting the function of the diaphragm and other inspiratory muscles. The measurement will be repeated three times, and the highest valid value will be recorded in centimeters of water. A higher absolute pressure value indicates greater inspiratory muscle strength, whereas a lower absolute pressure value indicates weaker inspiratory muscle strength.
4 weeks
Maximal Expiratory Pressure
時間枠：4 weeks
Maximal expiratory pressure will be used to assess expiratory muscle strength, particularly the strength of the abdominal and other expiratory muscles. The measurement will be repeated three times, and the highest valid value will be recorded in centimeters of water. A higher pressure value indicates greater expiratory muscle strength, whereas a lower pressure value indicates weaker expiratory muscle strength.
4 weeks
Medicine Ball Throw Distance
時間枠：4 weeks
Upper extremity explosive power will be assessed using the Medicine Ball Throw Test. The participant will sit with the back supported against a wall and the legs extended and will be instructed to throw the medicine ball as far as possible. Throwing distance will be measured in meters. A longer distance indicates greater upper extremity explosive power, whereas a shorter distance indicates lower explosive power.
4 weeks
Closed Kinetic Chain Upper Extremity Stability Test Score
時間枠：4 weeks
Upper extremity stability, strength, power, and endurance will be assessed using the Closed Kinetic Chain Upper Extremity Stability Test. The participant will assume a push-up position with the hands placed on two markers positioned 90 centimeters apart. The participant will alternately move each hand across the body to touch the opposite marker during the specified test period. The total number of valid touches will be recorded. A higher number of touches indicates better upper extremity functional performance and stability, whereas a lower number indicates poorer performance.
4 weeks
Scapular Muscular Endurance Time
時間枠：4 weeks
The functional endurance of the scapular stabilizing muscles will be assessed using the Scapular Muscular Endurance Test. An appropriately sized wooden rod will be positioned between the participant's elbows while both scapulae are maintained in a neutral position. The length of time for which the participant can maintain the standardized test position will be recorded in seconds. A longer duration indicates greater scapular muscular endurance, whereas a shorter duration indicates lower scapular muscular endurance.
4 weeks

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

Istinye University

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年8月30日

一次修了 (推定)

2026年11月15日

研究の完了 (推定)

2026年11月30日

試験登録日

最初に提出

2026年8月21日

QC基準を満たした最初の提出物

2026年8月21日

最初の投稿 (実際)

2026年8月25日

学習記録の更新

投稿された最後の更新 (実際)

2026年8月27日

QC基準を満たした最後の更新が送信されました

2026年8月25日

最終確認日

2026年8月1日

詳しくは

本研究に関する用語

キーワード

追加の関連 MeSH 用語

その他の研究ID番号

  • 2025/07

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する